Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Cited In for PubMed (Select 9547763)

1.

Effect of prenatal methamphetamine administration during gestational days on mice.

Khoradmehr A, Danafar A, Halvaei I, Golzadeh J, Hosseini M, Mirjalili T, Anvari M.

Iran J Reprod Med. 2015 Jan;13(1):41-8.

2.

A case-control study of maternal periconceptual and pregnancy recreational drug use and fetal malformation using hair analysis.

David AL, Holloway A, Thomasson L, Syngelaki A, Nicolaides K, Patel RR, Sommerlad B, Wilson A, Martin W, Chitty LS.

PLoS One. 2014 Oct 31;9(10):e111038. doi: 10.1371/journal.pone.0111038. eCollection 2014.

3.

Congenital abnormality effect of methamphetamine on histological, cellular and chromosomal defects in fetal mice.

Mirjalili T, Kalantar SM, Shams Lahijani M, Sheikhha MH, Talebi A.

Iran J Reprod Med. 2013 Jan;11(1):39-46.

4.

Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age.

Diaz SD, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Della Grotta S, Dansereau LM, Neal C, Lester BM.

J Pediatr. 2014 Jun;164(6):1333-8. doi: 10.1016/j.jpeds.2014.01.053. Epub 2014 Mar 12.

5.

Association between stillbirth and illicit drug use and smoking during pregnancy.

Varner MW, Silver RM, Rowland Hogue CJ, Willinger M, Parker CB, Thorsten VR, Goldenberg RL, Saade GR, Dudley DJ, Coustan D, Stoll B, Bukowski R, Koch MA, Conway D, Pinar H, Reddy UM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Stillbirth Collaborative Research Network.

Obstet Gynecol. 2014 Jan;123(1):113-25. doi: 10.1097/AOG.0000000000000052.

6.

Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment.

Abar B, LaGasse LL, Wouldes T, Derauf C, Newman E, Shah R, Smith LM, Arria AM, Huestis MA, DellaGrotta S, Dansereau LM, Wilcox T, Neal CR, Lester BM.

Prev Sci. 2014 Oct;15(5):767-76. doi: 10.1007/s11121-013-0431-5.

PMID:
23943149
7.

Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.

Shah R, Diaz SD, Arria A, LaGasse LL, Derauf C, Newman E, Smith LM, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Roberts MB, Neal C, Lester BM.

Am J Perinatol. 2012 May;29(5):391-400. doi: 10.1055/s-0032-1304818. Epub 2012 Mar 7.

8.

Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women.

Wright TE, Schuetter R, Fombonne E, Stephenson J, Haning WF 3rd.

Harm Reduct J. 2012 Jan 19;9:5. doi: 10.1186/1477-7517-9-5.

9.

The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age.

Zabaneh R, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau LM, Lin H, Neal C, Lester BM.

Am J Perinatol. 2012 Mar;29(3):203-10. doi: 10.1055/s-0031-1285094. Epub 2011 Aug 4.

10.

Drugs of abuse and human placenta.

Ganapathy V.

Life Sci. 2011 May 23;88(21-22):926-30. doi: 10.1016/j.lfs.2010.09.015. Epub 2010 Oct 16. Review.

11.

Cockayne syndrome B protects against methamphetamine-enhanced oxidative DNA damage in murine fetal brain and postnatal neurodevelopmental deficits.

McCallum GP, Wong AW, Wells PG.

Antioxid Redox Signal. 2011 Mar 1;14(5):747-56. doi: 10.1089/ars.2009.2946. Epub 2011 Jan 5.

12.

Fetal effects of psychoactive drugs.

Salisbury AL, Ponder KL, Padbury JF, Lester BM.

Clin Perinatol. 2009 Sep;36(3):595-619. doi: 10.1016/j.clp.2009.06.002. Review.

13.

Drugs, biogenic amine targets and the developing brain.

Frederick AL, Stanwood GD.

Dev Neurosci. 2009;31(1-2):7-22. doi: 10.1159/000207490. Epub 2009 Apr 17. Review.

14.

Neonatal amphetamine exposure and hippocampus-mediated behaviors.

Smith AM, Chen WJ.

Neurobiol Learn Mem. 2009 Mar;91(3):207-17. doi: 10.1016/j.nlm.2008.12.005. Epub 2009 Jan 23.

15.

Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents.

Embry D, Hankins M, Biglan A, Boles S.

Addict Behav. 2009 Apr;34(4):343-51. doi: 10.1016/j.addbeh.2008.11.019. Epub 2008 Nov 27.

16.

Prenatal methamphetamine use and neonatal neurobehavioral outcome.

Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Fallone M, Liu J, Lester BM.

Neurotoxicol Teratol. 2008 Jan-Feb;30(1):20-8. Epub 2007 Oct 3.

17.

Exposure to attention deficit hyperactivity disorder medications during pregnancy.

Humphreys C, Garcia-Bournissen F, Ito S, Koren G.

Can Fam Physician. 2007 Jul;53(7):1153-5. Review.

18.

Periventricular leukomalacia and prenatal methamphetamine exposure: a case report.

Murphy CR, Bell EF, Sato Y, Klein JM.

Am J Perinatol. 2007 Feb;24(2):123-6. Epub 2007 Feb 15.

19.

A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Piper BJ.

Neurotoxicol Teratol. 2007 Mar-Apr;29(2):288-300. Epub 2006 Oct 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk